4 TREATMENT PROTOCOL Your new treatment program will inform therapy
For comparison, the FDA's 2003 guidance on pharmacokinetics in patients with impaired hepatic function recommends that drugs primarily cleared by the liver undergo dedicated studies across Child-Pugh categories A, B, and C [9]
However, it is worth considering what would happen if we had chosen a different value, such as 60% or 100%
Furthermore, the study of Alberti et al
Bottom line: Start with lifestyle foundations, choose bioavailable formulas, and always consult a healthcare professional before increasing your dosage beyond standard recommendations
Glutathione levels in the body may be reduced by a number of factors, including poor nutrition, environmental toxins, and stress